Osteonecrosis of the jaw in patients with dental prostheses being treated with bisphosphonates or denosumab

被引：35
|
作者：
Niibe, Kunimichi [1 ]
Ouchi, Takehito [1 ]
Iwasaki, Ryotaro [1 ]
Nakagawa, Taneaki [1 ]
Horie, Nobuyuki [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Dent & Oral Surg, Shinjuku Ku, Tokyo 1508582, Japan
来源：
JOURNAL OF PROSTHODONTIC RESEARCH | 2015年 / 59卷 / 01期
关键词：
Medication-related osteonecrosis of the jaw (MRONJ); Bisphosphonate; Denosumab; Removable denture; Fixed partial denture;
D O I：
10.1016/j.jpor.2014.08.001
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
引用
收藏
页码：3 / 5
页数：3
相关论文
共 50 条
  • [41] Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates
    P.D. Miller
    N. Pannacciulli
    J. Malouf-Sierra
    A. Singer
    E. Czerwiński
    H.G. Bone
    C. Wang
    S. Huang
    A. Chines
    W. Lems
    J.P. Brown
    Osteoporosis International, 2020, 31 : 181 - 191
  • [42] Correlating the Prevalence of bisphosphonate-associated Osteonecrosis of the Jaw with the Duration of Onset of Bisphosphonates in Tumor and Osteoporosis Patients? Overall Evaluation of the German Osteonecrosis of the Jaw Registry
    Karberg, Niels
    Felsenberg, Dieter
    JOURNAL FUR MINERALSTOFFWECHSEL & MUSKULOSKELETTALE ERKRANKUNGEN, 2020, 27 (01): : 8 - 18
  • [43] Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates
    Miller, P. D.
    Pannacciulli, N.
    Malouf-Sierra, J.
    Singer, A.
    Czerwinski, E.
    Bone, H. G.
    Wang, C.
    Huang, S.
    Chines, A.
    Lems, W.
    Brown, J. P.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (01) : 181 - 191
  • [44] A real-world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab
    Bracchi, Paola
    Zecca, Ernesto
    Brunelli, Cinzia
    Miceli, Rosalba
    Tine, Gabriele
    Maniezzo, Massimo
    Lo Dico, Silvia
    Caputo, Mariangela
    Shkodra, Morena
    Caraceni, Augusto T. T.
    CANCER MEDICINE, 2023, 12 (17): : 18317 - 18326
  • [45] Duration of treatment with bisphosphonates at the time of osteonecrosis of the jaw onset in patients with rheumatoid arthritis. Review
    Compain, H.
    Berquet, A.
    Loison-Robert, L. -S.
    Ahossi, V.
    Zwetyenga, N.
    JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY, 2018, 119 (03) : 177 - 181
  • [46] Evaluation of appropriate use of bisphosphonates and denosumab in patients with cancer
    Gyori, Derek J.
    Bullington, Susan M.
    Crawford, Brooke S.
    Vernon, Veronica P.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (02) : 286 - 292
  • [47] Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates
    Endo, Yasuo
    Funayama, Hiromi
    Yamaguchi, Kouji
    Monma, Yuko
    Yu, Zhiqian
    Deng, Xue
    Oizumi, Takefumi
    Shikama, Yosuke
    Tanaka, Yukinori
    Okada, Satoshi
    Kim, Siyoung
    Kiyama, Tomomi
    Bando, Kanan
    Shima, Kazuhiro
    Suzuki, Hikari
    Takahashi, Tetsu
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2020, 140 (01): : 63 - 79
  • [48] Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis
    Hansen, T
    Kunkel, M
    Weber, A
    Kirkpatrick, CJ
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2006, 35 (03) : 155 - 160
  • [49] Medication-related osteonecrosis of the jaw in patients with cancer using zoledronic acid and denosumab: Single-center retrospective study
    Sano, Motohiko
    Amano, Mai
    Yamada, Miki
    Iijima, Yosuke
    Hino, Shunsuke
    Sakagami, Hiroshi
    Horie, Norio
    Kaneko, Takahiro
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025,
  • [50] Osteonecrosis of the jaw (ONJ) in renal cell cancer patients after treatment including zoledronic acid or denosumab
    Vittorio Fusco
    Alberto Bedogni
    Giuseppina Campisi
    Supportive Care in Cancer, 2014, 22 : 1737 - 1738
12345